Table 2. EFV-modulated metastamiRs, miRNAs promoting tumor progression, invasiveness and metastasis.
Name | EFV modulation |
Modulation in cancer | Biological correlation | Cancer type | References |
---|---|---|---|---|---|
miR-21 | down | up | Correlated with invasion and metastasis | lung, colorectal, | 61,62 |
miR-33a | down | up | Dysregulated expression in bone metastasis from primary prostate | prostate | 63 |
miR-181a | down | up | Related with shortened disease-free survival, highly upregulated in osteosarcoma | osteosarcoma | 57 |
miR-199b | down | up | Expression dysregulated in metastasis | brain | 64 |
miR-34b | up | down | Downregulated in metastasis, reactivated upon drug treatment inhibits tumor growth and lymph node metastasis | colorectal, melanoma, head and neck | 65 |
miR-125b | up | down/up | Downregulated in breast and upregulated in i cancer, association with cancer metastasis | breast, colorectal | 37 |
miR-146a | up | down | Inversely correlated expression with cancer progression and metastasis | prostate, breast | 66 |
miR-148a | up | down | Downregulated in metastasis, acts as metastasis suppressor inhibiting tumor growth and lymph node metastasis | colorectal, melanoma, head and neck | 65 |
miR-193b | up | down | Inversely correlated expression with cancer progression, invasion and metastasis | breast | 67 |
miR-204 | up | down | Highly reduced expression in cancer progression; overexpression suppresses invasiveness and acts as metastasis suppressor | head and neck | 68 |